Back to Journals » Drug Design, Development and Therapy » Volume 9

Crizotinib as a personalized alternative for targeted anaplastic lymphoma kinase rearrangement in previously treated patients with non-small-cell lung cancer

Total article views   HTML views PDF downloads Totals
15,889 Dovepress* 14,709+ 1,611 16,320
PubMed Central* 1,180 322 1,502
Totals 15,889 1,933 17,822
*Since 3 October 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar